Search for: "IPR Licensing Inc." Results 21 - 40 of 278
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Feb 2022, 6:12 pm by Dennis Crouch
Daktronics, Inc., et al., No. 21-438 (CVSG requested October 4, 2021); and Appellate Standing for IPR Challenger: Apple Inc. v. [read post]
16 Jan 2022, 6:00 pm by Juvan Bonni
– Seattle, WA American Honda Motor Company, Inc. [read post]
14 Dec 2021, 9:57 am by Dennis Crouch
Here, Apple licensed a large number of Qualcomm patents as part of a portfolio license, but has only challenged a couple of them via IPR. [read post]
10 Nov 2021, 2:30 pm by Lawrence B. Ebert
IPR petitioners, for example, “may lack constitutional standing. [read post]
24 Sep 2021, 4:12 am by Merpel McKitten
For example, Nokia has argued that “[r]equiring component-level licensing contravenes industry norms, leads to the ATIS and TIA IPR Policies being inconsistent with the ETSI IPR Policy, and could have unintended consequences for other SEP holders and the industry at large. [read post]
22 Jul 2021, 9:15 am by Jonathan Stroud
The long-running Ancora Technologies, Inc. assertion has moved on to additional defendants and a number of parties filed IPRs against the Magentar-Capital-backed Arigna Technologies this week. [read post]
16 Jun 2021, 11:59 am by Jason Rantanen
Nike, Inc., 568 U.S. 85 (2013)), or dedicated to the public under 35 U.S.C. [read post]
7 Jun 2021, 6:36 am by Dennis Crouch
MedImmune Licensee Standing Does not Apply to Portfolio License The Case: After some litigation, Apple eventually licensed 20,000+ Qualcomm patents in a six-year-deal.* Meanwhile, Apple also pursued inter partes review (IPR) of two of the licensed patents. [read post]
5 Oct 2020, 10:25 am by Dennis Crouch
Appealing IPR Termination:BioDelivery Sciences International, Inc. v. [read post]
27 Sep 2020, 6:36 pm by Dennis Crouch
Appealing IPR Termination: BioDelivery Sciences International, Inc. v. [read post]